Dermapharm Holding SE (DMPHF)

Market Cap	2.13B +3.5%
Revenue (ttm)	1.35B +0.4%
Net Income	167.41M +36.7%
EPS	3.11 +39.0%
Shares Out	n/a
PE Ratio	15.33
Forward PE	13.00
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Open	47.69
Previous Close	53.00
Day's Range	47.69 - 47.69
52-Week Range	47.69 - 59.00
Beta	0.86
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2026

About Dermapharm Holding SE

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China. The company operates through three segments: Branded Pharmaceuticals; Other Healthcare Products; and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1991
• Employees: 3,619
• Stock Exchange: OTCMKTS
• Ticker Symbol: DMPHF

Financial Performance

In 2025, Dermapharm Holding SE's revenue was 1.17 billion, a decrease of -1.32% compared to the previous year's 1.18 billion. Earnings were 132.41 million, an increase of 16.37%.

Financial numbers in EUR

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 9, 2026

Data Sources Report a data error